World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
125
Citations
64985
World Ranking
3063
National Ranking
1692

Douglas B. Evans publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Douglas B. Evans sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 708 publications — 81st percentile

81% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Douglas B. Evans D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Douglas B. Evans sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 125 D-Index — 85th percentile

85% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Douglas B. Evans is affiliated with the Medical College of Wisconsin in the United States. Their research focuses primarily on the fields of Medicine and Biochemistry, Genetics, and Molecular Biology, with a substantial number of publications totaling 264 and 64 respectively.

The main areas of study for Evans include Oncology, Cancer Research, Surgery, Endocrinology, Diabetes and Metabolism, and Pulmonary and Respiratory Medicine. These subfields reflect the diversity and focus of their scientific investigations.

Evans has contributed to the following primary research topics:

  • Pancreatic and Hepatic Oncology Research
  • Cancer Genomics and Diagnostics
  • Renal Cell Carcinoma Treatment
  • Neuroendocrine Tumor Research Advances
  • Hormonal Regulation and Hypertension
  • Parathyroid Disorders and Treatments
  • Pancreatitis Pathology and Treatment

Their recent publications demonstrate a broad engagement with pancreatic cancer, surgical oncology, and quality of life studies. Notable papers include:

  • "An Exosome-based Transcriptomic Signature for Noninvasive, Early Detection of Patients With Pancreatic Ductal Adenocarcinoma: A Multicenter Cohort Study" (2022, Gastroenterology)
  • "Adjuvant therapy rates and overall survival in patients with localized pancreatic cancer from high Area Deprivation Index neighborhoods" (2020, The American Journal of Surgery)
  • "Long-term Quality of Life After Parathyroidectomy for Primary Hyperparathyroidism" (2022, JAMA Surgery)
  • "Total Neoadjuvant Therapy for Operable Pancreatic Cancer" (2020, Annals of Surgical Oncology)
  • "Pancreatic neuroendocrine neoplasms: current state and ongoing controversies on terminology, classification and prognostication" (2020, Journal of Gastrointestinal Oncology)

Evans frequently collaborates with other researchers, with some coauthors appearing multiple times. Frequent collaborators include Susan Tsai, Kathleen K. Christians, William A. Hall, Mandana Kamgar, and Mohammed Aldakkak.

Publication venues where Evans has contributed extensively include:

  • Journal of Clinical Oncology
  • Surgery
  • HPB
  • Annals of Surgical Oncology
  • Cancer Research

Best Publications

  • One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States

    James C. Yao;Manal Hassan;Alexandria T. Phan;Cecile Dagohoy

  • Revised American thyroid association guidelines for the management of medullary thyroid carcinoma

    Samuel A Wells;Sylvia L Asa;Henning Dralle;Rossella Elisei

  • Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement

    Mary C. Frates;Carol B. Benson;J. William Charboneau;Edmund S. Cibas

  • Medullary thyroid cancer: management guidelines of the American Thyroid Association.

    Richard T. Kloos;Charis Eng;Douglas B. Evans;Gary L. Francis

  • Cancer-Associated Stromal Fibroblasts Promote Pancreatic Tumor Progression

    Rosa Frances Hwang;Todd Moore;Thiruvengadam Arumugam;Vijaya Ramachandran

  • Borderline Resectable Pancreatic Cancer: Definitions, Management, and Role of Preoperative Therapy

    Gauri R. Varadhachary;Eric P. Tamm;James L. Abbruzzese;Henry Q. Xiong

  • The Nuclear Factor-κB RelA Transcription Factor Is Constitutively Activated in Human Pancreatic Adenocarcinoma Cells

    Weixin Wang;James L. Abbruzzese;Douglas B. Evans;Lillie Larry

  • Borderline resectable pancreatic cancer: the importance of this emerging stage of disease.

    Matthew H.G. Katz;Peter W.T. Pisters;Douglas B. Evans;Charlotte C. Sun

  • Preoperative Gemcitabine-Based Chemoradiation for Patients With Resectable Adenocarcinoma of the Pancreatic Head

    Douglas B. Evans;Gauri R. Varadhachary;Christopher H. Crane;Charlotte C. Sun

  • Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas.

    Douglas B. Evans;Tyvin A. Rich;David R. Byrd;Karen R. Cleary

  • Fluorouracil, Doxorubicin, and Streptozocin in the Treatment of Patients With Locally Advanced and Metastatic Pancreatic Endocrine Carcinomas

    Maria A. Kouvaraki;Jaffer A. Ajani;Paulo Hoff;Robert Wolff

  • Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer

    Maria A Kouvaraki;Suzanne E Shapiro;Bruno D Fornage;Beth S Edeiken-Monro

  • Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma

    Chandrajit P. Raut;Jennifer F. Tseng;Jennifer F. Tseng;Charlotte C. Sun;Huamin Wang

  • Pancreaticoduodenectomy with vascular resection: margin status and survival duration

    Jennifer F. Tseng;Chandrajit P. Raut;Jeffrey E. Lee;Peter W.T. Pisters

  • Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas.

    F. R. Spitz;J. L. Abbruzzese;Jeffrey E Lee;Peter W Pisters

  • Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms.

    Christiane J. Bruns;Matthew T. Harbison;Darren W. Davis;Charles A. Portera

  • Long-Term Survival After Multidisciplinary Management of Resected Pancreatic Adenocarcinoma

    Matthew Harold Katz;Matthew Harold Katz;Huamin Wang;Jason B Fleming;Charlotte C Sun

  • HIF-1α, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas

    Michael J Gray;Jing Zhang;Jing Zhang;Lee M Ellis;Gregg L Semenza

  • Preoperative Gemcitabine and Cisplatin Followed by Gemcitabine-Based Chemoradiation for Resectable Adenocarcinoma of the Pancreatic Head

    Gauri R. Varadhachary;Robert A. Wolff;Christopher H. Crane;Charlotte C. Sun

  • NF-κB and AP-1 Connection: Mechanism of NF-κB-Dependent Regulation of AP-1 Activity

    Shuichi Fujioka;Jiangong Niu;Christian Schmidt;Guido M. Sclabas

Frequent Co-Authors

Jeffrey E. Lee
Jeffrey E. Lee The University of Texas MD Anderson Cancer Center
James L. Abbruzzese
James L. Abbruzzese Duke University
Robert A. Wolff
Robert A. Wolff The University of Texas MD Anderson Cancer Center
Peter W.T. Pisters
Peter W.T. Pisters The University of Texas MD Anderson Cancer Center
Christopher H. Crane
Christopher H. Crane Memorial Sloan Kettering Cancer Center
Jason B. Fleming
Jason B. Fleming The University of Texas MD Anderson Cancer Center
Karen R. Cleary
Karen R. Cleary The University of Texas MD Anderson Cancer Center
Huamin Wang
Huamin Wang The University of Texas MD Anderson Cancer Center
Jean Nicolas Vauthey
Jean Nicolas Vauthey The University of Texas MD Anderson Cancer Center
Robert F. Gagel
Robert F. Gagel The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in healthcare but considering alternate routes beyond a traditional M.D. pathway, there are flexible options available online. Aspiring nurses from non-nursing backgrounds may appreciate the convenience of msn direct entry programs online. These accelerated degrees can quickly put you on a track to advanced practice nursing roles.

Entry requirements and acceptance rates often vary between institutions. If you’re concerned about competitiveness, you may want to consider nursing schools with high acceptance rates, which can offer more accessible routes to launching your healthcare career.

Not all medical careers require clinical work. There is high demand for skilled professionals in healthcare administration as well. Studying at one of the best medical billing and coding schools online can open doors in the growing field of health information management, often with flexible schedules and financial aid options.

Some students prefer programs with fewer standardized exam barriers. If that’s you, explore a nursing school that does not require teas test, allowing you to begin your studies without the stress of additional entrance exams.

Best Scientists Citing Douglas B. Evans

Trending Scientists

Recently Published Articles